Navartis has now secured regulatory approval for---- CUBICIN---- in some additional countries, and is planning TO LAUNCH WITH THESE NEXT MONTHS----- Turkey, Russia,Mexico, Brazil, and Australia and New Zealand----Navartis should make at lot by this and a LOT more IF THEY BUY CUBIST PHARM. IN THE U.S.------------(CBST is going to make $1 Bill in the U.S.)CBST is working on other drugs to. Two phase II and two phase I drugs.
Novartis has now secured regulatory approval for CUBICIN in some additional countries and to LAUNCH NOW in Turkey,Russia,Mexico,Brazil and Australia and New Zealand----Novartis could make more by a lot------BUYING CUBIST PHARM.(CBST will in the outlook future sell CUBICIN $1 Bill in the U.S.) Also CBST is working on several other drugs 2 on phase I and 2 on phase II